Helix BioPharma (TSX:HBP) Total Current Assets : C$0.40 Mil (As of Oct. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Helix BioPharma's total current assets for the quarter that ended in Oct. 2024 was C$0.40 Mil.

Helix BioPharma Total Current Assets Historical Data

The historical data trend for Helix BioPharma's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma Total Current Assets Chart

Helix BioPharma Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Total Current Assets

Get a 7-Day Free Trial

4.66

4.02

3.70

1.00

1.46

Helix BioPharma Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Total Current Assets	Get a 7-Day Free Trial															1.85	0.31	1.11	1.46	0.40

Helix BioPharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Helix BioPharma's Total Current Assets for the fiscal year that ended in Jul. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.081	+	0.054	+	0	+	0.321
	=	1.46

Helix BioPharma's Total Current Assets for the quarter that ended in Oct. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	0.228	+	0.176	+	0	+	0
	=	0.40

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Helix BioPharma (TSX:HBP) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Helix BioPharma's Liquidation Value for the quarter that ended in Oct. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.228	-	1.778	+	0.75 * 0	+	0.5 * 0
=	-1.55

Helix BioPharma Total Current Assets Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

HBPCF:USA HBP0:Germany

Address

40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.